Masaaki Akai, Shinya Otsuka, Yuichi Yasui, Kenta Isoda, Ryousuke Hamano, Naoyuki Tokunaga, Kenji Takahashi, Hideaki Miyaso, Yousuke Tsunemitsu, Kazuhide Iwakawa, Masaru Inagaki, Hiromi Iwagaki
The patient was a man in his early 30s. He underwent sigmoidectomy with D3+ #216 for advanced sigmoid colon cancer with metastatic para-aortic lymph nodes. The pathological diagnosis was colon cancer(S), type 2, moderately differentiated, pT4a(SE), pN3(19/33), pM1a(LYM), pStage IV , KRAS wild-type, EGFR(+). He received FOLFOX plus bevacizumab(Bmab) as adjuvant chemotherapy. One year postoperatively, he experienced recurrence as multiple lung metastases. FOLFIRI plus panitumumab, SOX plus Bmab, CapeOX, nivolumab and FOLFIRI plus ramucirumab were then administered...
November 2017: Gan to Kagaku Ryoho. Cancer & Chemotherapy